Zahi Mitri
Medical Oncology · Portland, ORNPI 1942514476
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $10,278 of the $13,163 with a category attached, or 78.1%. 10 manufacturers reported payments, led by AstraZeneca at 39.2% of the total. Reporting peaked in 2021 at $4,527 and has fallen 80.5% since, to $884 in 2025.
Across 43 payments — averaging $306.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$5K
- Eli Lilly$3K
- Daiichi Sankyo Inc.$2K
- Gilead$968
- Novartis Pharma AG$884
- Pfizer$297
- plus $431 from 4 others
Across 302 payments — averaging $28,065 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AstraZeneca$5.2M
- GSK$1.2M
- Seagen Inc.$811K
- Novartis$527K
- Daiichi Sankyo Inc.$342K
- Merck$182K
- plus $282K from 6 others
What the payments were for
- Consulting fees$10,27878%
- Travel & lodging$1,25910%
- Food & beverage$1,60312%
- Education$230%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 8 | $5,164 |
| Eli Lilly | 19 | $3,175 |
| Daiichi Sankyo Inc. | 3 | $2,244 |
| Gilead | 6 | $968 |
| Novartis Pharma AG | 1 | $884 |
| Pfizer | 2 | $297 |
| Covis Pharma GmbH | 1 | $200 |
| Genentech USA, Inc. | 1 | $121 |
| Genentech, Inc. | 1 | $100 |
| Merck | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$13,163 in reported general payments places this provider in the 75th percentile of 92 medical oncology providers in Oregon.
Other medical oncology in Portland
- David PagePortland$238K
- Rachel SanbornPortland$233K
- Matthew TaylorPortland$231K
- Tomasz BeerPortland$102K
- Alison ConlinPortland$85K
- Shivaani KummarPortland$66K
- Stacy LewisPortland$57K
- Hagen KenneckePortland$53K
- Adel KardoshPortland$51K
- Brendan CurtiPortland$49K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.